David Hahn, MD
December 1, 2022
HistoSonics Announces First Ever Kidney Tumor Treatment Using Histotripsy
HistoSonics announced today the first kidney patient has been treated using the Company's histotr...
HistoSonics Announces FDA Approval of its Pivotal IDE #HOPE4KIDNEY Trial
HistoSonics announced today the US Food and Drug Administration (FDA) has approved the company sp...